01
Cash & equivalents increased 114.2%
Cash & equivalents changed +114.2% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
$12.6M→$26.9MComparable → current
· Pharmaceutical Preparations
RESEARCH SNAPSHOTFaeth Therapeutics, Inc.'s latest supported as-filed period reports net income of -$16.0M, 224.3% below the comparable as-filed period. Every value below links to its SEC accession and metric lineage.
The most important deterministic changes, ranked by magnitude, issuer history, persistence, and accounting profile.
Cash & equivalents changed +114.2% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Net income changed -224.3% from the comparable as-filed period.
Operating income changed -253.2% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Each point keeps the date investors could first observe it and its accession.
FTH · as filed with the SEC · reported-date aware
Direct SEC links, filing dates, report periods, and amendment flags.
0001193125-26-331562SEC ↗8-KAug 4, 2026Period Aug 4, 20260001193125-26-331563SEC ↗8-KJul 23, 2026Period Jul 21, 20260001193125-26-314591SEC ↗4Jul 23, 2026Period Jul 21, 20260002038400-26-000004SEC ↗4Jul 23, 2026Period Jul 21, 20260002111813-26-000012SEC ↗4Jul 1, 2026Period Jun 29, 20260001780030-26-000006SEC ↗4Jun 26, 2026Period Jun 24, 20260001780030-26-000005SEC ↗Transaction semantics distinguish purchases, sales, awards, exercises, withholding, and derivatives.
| Filed / transacted | Reporting owner | Semantics | Shares | Price | Notional | Source |
|---|---|---|---|---|---|---|
| Jul 21, 2026Filed Jul 23, 2026 | Craver JosiahPAO | Grant Or AwardDirect | 30,824 | $0 | $0 | Form 4 ↗ |
GrossPattern stores immutable raw artifacts, accession-scoped facts, parser and metric versions, dependency edges, quality state, and channel-specific publication rights. A restricted or unknown ancestor blocks the page and API automatically.
SEC source policy ↗Stock-based compensation changed +1598.1% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Method note “Materiality” here is an analytical magnitude band, not a legal conclusion. Full filing-text semantic changes remain unpublished while excerpt rights and review thresholds are unresolved.
Latest supported period in this snapshot: 2026-06-30. Duration facts use direct quarterly or annual SEC contexts; GrossPattern does not manufacture missing Q4 values.
0001780030-26-000004